Moleculera Biosciences is a precision medicine company focused on identifying and directing treatment for immune-mediated causes of chronic debilitating disorders. Through our fully-accredited CLIA/COLA clinical laboratory, we specialize in molecular diagnostic testing for autoimmune neuroimmunology. As pioneers focusing on neuropsychiatric disorders caused by molecular mimicry, we offer the Autoimmune Brain Panel™, an aid to a physician’s diagnosis of autoimmune-based neuropsychiatric disorders.
The Autoimmune Brain Panel™ helps identify whether an individual’s neurologic/psychiatric symptoms, such as obsessive compulsive behaviors, tics, anxiety, attention deficit hyperactivity disorder, and sometimes behaviors associated with Autism Spectrum Disorders, could be caused by a treatable autoimmune condition triggered by common infections.
Company Details
- Employees
- 12
- Founded
- 2011
- Address
- 755 Research Pkwy,
- Industry
- Biotechnology
- Website
- http://www.moleculera.com
- Keywords
- Immunology, Lyme Disease, Autoimmune Encephalopathy, PANDAS/PANS, Neuropsychiatric Illness.
- HQ
- Oklahoma City, Oklahoma
Moleculera Biosciences Questions
Moleculera Biosciences's website is http://www.moleculera.com
Moleculera Biosciences's LinkedIn profile is https://www.linkedin.com/company/moleculera-biosciences
Moleculera Biosciences has
12 employees.
View email and phone details for 12
employees at Moleculera Biosciences.
Moleculera Biosciences's industry is
Biotechnology
Moleculera Biosciences's top competitors are
1871,
General Genomics Inc.,
Wheeler Bio, Inc.,
Biotc Oklahoma,
Oklahoma Medical Research Foundation,
Cadenza Bio,
Cytovance Biologics,
Arl Bio Pharma,
Okbiostart,
Immy.
Moleculera Biosciences's categories are Biotechnology
Moleculera Biosciences's founding year is 2011
